Evolution and Management of Treatment-Related Toxicity in Anal Cancer.

Published

Journal Article (Review)

Over the past several decades, clinical trials have demonstrated improved disease-related outcomes in the definitive treatment of anal cancer. Although treatment with radiation and concurrent chemotherapy results in high rates of cure, significant acute and late toxicities are seen. This review focuses on the evolution of treatment-related toxicity for anal cancer. Management of these adverse effects is reviewed, as are future directions in anal cancer treatment and their impact on toxicity.

Full Text

Duke Authors

Cited Authors

  • Ludmir, EB; Kachnic, LA; Czito, BG

Published Date

  • January 2017

Published In

Volume / Issue

  • 26 / 1

Start / End Page

  • 91 - 113

PubMed ID

  • 27889040

Pubmed Central ID

  • 27889040

Electronic International Standard Serial Number (EISSN)

  • 1558-5042

Digital Object Identifier (DOI)

  • 10.1016/j.soc.2016.07.004

Language

  • eng

Conference Location

  • United States